Brief: Perspective Therapeutics Q2 EPS USD -0.22
10/08/2026 21:23
BRIEF-Perspective Therapeutics Q2 EPS USD -0.22 Aug 10 (Reuters) - Perspective Therapeutics Q2 net income USD -26.786 million.
- Q2 grant revenue USD 81 thousand
- Q2 net income from cont ops USD -26.983 million
- Q2 operating income USD -29.258 million
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise